Longitudinal change of liver stiffness by transient elestography in chronic hepatitis B patients treated with nucleos(t)ide analogue

Clinics and Research in Hepatology and Gastroenterology

Volumn 38, Issue 2, 2014, Pages 195-200

  Jang, Won ^a   Yu, Sung In ^a   Sinn, Dong Hyun ^a   Park, Sang Hoon ^a   Park, Hyun ^a   Park, Ji Young ^a   Jeon, Tae Joo ^a   Oh, Tae Hoon ^a   Shin, Won Chang ^a   Choi, Won Choong ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CLEVUDINE; ENTECAVIR; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; NUCLEOSIDE ANALOG; VIRUS DNA; ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; NUCLEOSIDE; NUCLEOTIDE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; COMPLETE VIROLOGICAL RESPONSE; CONTROLLED STUDY; ELASTOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER STIFFNESS; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OUTCOME ASSESSMENT; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RIGIDITY; THROMBOCYTE COUNT; TRANSIENT ELASTOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; BLOOD; COHORT ANALYSIS; ECHOGRAPHY; GENETICS; HEPATITIS B, CHRONIC; LIVER CIRRHOSIS; MIDDLE AGED;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; COHORT STUDIES; DNA, VIRAL; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NUCLEOSIDES; NUCLEOTIDES; RETROSPECTIVE STUDIES;

EID: 84899472307     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2013.10.003     Document Type: Article

References (21)

1. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012;57:167-85.
2. Rockey D.C., Caldwell S.H., Goodman Z.D., Nelson R.C., Smith A.D. Liver biopsy. Hepatology 2009, 49:1017-1044.
3. Jung K.S., Kim S.U. Clinical applications of transient elastography. Clin Mol Hepatol 2012, 18:163-173.
4. Castera L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat 2009, 16:300-314.
5. Castéra L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Haaser M., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005, 128:343-350.
6. Foucher J., Chanteloup E., Vergniol J., Castera L., Le Bail B., Adhoute X., et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006, 55:403-408.
7. Friedrich-Rust M., Ong M.F., Martens S., Sarrazin C., Bojunga J., Zeuzem S., et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008, 134:960-974.
8. Roulot D., Costes J.L., Buyck J.F., Warzocha U., Gambier N., Czernichow S., et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45years. Gut 2011, 60:977-984.
9. Fung J., Lai C.L., Wong D.K., Seto W.K., Hung I., Yuen M.F. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study. J Viral Hepat 2011, 18:e200-e205.
10. Kim S.U., Park J.Y., Kim do Y., Ahn S.H., Choi E.H., Seok J.Y., et al. Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression. Hepatol Int 2010, 4:673-680.
11. Lim S.G., Cho S.W., Lee Y.C., Jeon S.J., Lee M.H., Cho Y.J., et al. Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B. Hepatogastroenterology 2011, 58:539-545.
12. Keeffe E.B., Zeuzem S., Koff R.S., Dieterich D.T., Esteban-Mur R., Gane E.J., et al. Report of an international workshop: roadmap for management of patients receiving oral therapy for chronic hepatitis B. Clin Gastroenterol Hepatol 2007, 5:890-897.
13. Boursier J., Zarski J.P., de Ledinghen V., Rousselet M.C., Sturm N., Lebail B., et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology 2013, 57:1182-1191.
14. KASL Clinical Practice Guidelines: management of chronic hepatitis B. Clin Mol Hepatol 2012;18:109-62.
15. Wong G.L., Wong V.W., Choi P.C., Chan A.W., Chim A.M., Yiu K.K., et al. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. Antivir Ther 2011, 16:165-172.
16. Fung J., Lai C.L., Cheng C., Wu R., Wong D.K., Yuen M.F. Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B. Am J Gastroenterol 2011, 106:492-496.
17. Enomoto M., Mori M., Ogawa T., Fujii H., Kobayashi S., Iwai S., et al. Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: regression of liver stiffness during entecavir therapy. Hepatol Res 2010, 40:853-861.
18. Jung K.S., Kim S.U., Ahn S.H., Park Y.N., Kim do Y., Park J.Y., et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011, 53:885-894.
19. de Ledinghen V., Vergniol J., Barthe C., Foucher J., Chermak F., Le Bail B., et al. Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus. Aliment Pharmacol Ther 2013, 37:979-988.
20. Mommeja-Marin H., Mondou E., Blum M.R., Rousseau F. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 2003, 37:1309-1319.
21. Osakabe K., Ichino N., Nishikawa T., Sugiyama H., Kato M., Kitahara S., et al. Reduction of liver stiffness by antiviral therapy in chronic hepatitis B. J Gastroenterol 2011, 46:1324-1334.